studi
conduct
evalu
feasibl
use
canin
herpesviru
chv
vaccin
vector
baitdeliv
oral
vaccin
wild
fox
test
viabil
chv
bait
chv
freezedri
incorpor
differ
bait
store
remain
viral
infect
test
cell
cultur
vari
period
time
differ
storag
temperatur
experiment
bait
mous
carcass
commerci
bait
foxoff
probait
prepar
either
liquid
freezedri
chvand
test
two
fox
trial
capac
induc
chvspecif
antibodi
follow
oral
bait
freezedri
storag
temperatur
stabil
effect
viru
infect
store
freezedri
chv
retain
full
infect
month
probait
bait
remain
infect
foxoff
bait
less
oral
bait
chv
induc
antivir
serum
antibodi
vaccin
fox
none
vaccin
fox
becam
ill
shed
infecti
viru
environ
although
viral
dna
detect
bodi
secret
evalu
pcr
result
indic
chv
freezedri
store
extend
period
time
without
loos
much
infect
first
report
chv
use
oral
bait
vaccin
fox
appear
chv
well
suit
use
recombin
vector
wild
canid
major
veterinari
antivir
vaccin
current
use
domest
dog
develop
classic
laboratori
method
viru
attenu
inactiv
vaccin
proven
safe
highli
effect
combat
mani
import
viral
diseas
domest
dog
distemp
parvovirosi
rabi
carmichael
rabi
vaccin
success
use
also
wild
canid
particular
fox
coyot
racoon
immun
via
oral
bait
practic
largescal
method
woldehiwet
howev
addit
wellknown
infecti
epidem
wildlif
manag
like
face
novel
challeng
futur
exampl
newli
emerg
wwwelseviercomlocatevetm
veterinari
microbiolog
diseas
sever
acut
respiratori
syndrom
among
variou
wildlif
speci
china
nippah
viru
epidem
pig
malaysia
recent
zoonot
avian
influenza
case
south
east
asia
bengi
et
al
daszak
et
al
peiri
et
al
audsley
tannock
develop
vaccin
emerg
infect
timeconsum
costli
especi
convent
method
viru
attenu
inactiv
appli
overabund
certain
wildlif
speci
anoth
challeng
wildlif
manag
antifertil
vaccin
also
known
immunocontracept
current
develop
attempt
address
problem
associ
overabund
wildlif
fox
australia
overabund
introduc
european
red
fox
pose
major
threat
surviv
endang
nativ
fauna
also
consider
impact
lamb
product
antifertil
vaccin
particularli
appeal
use
fox
human
nonleth
approach
potenti
reduc
size
pest
anim
popul
reduc
recruit
rather
increas
mortal
review
see
ferro
research
antifertil
vaccin
fundament
differ
develop
antivir
vaccin
aim
antivir
vaccin
confer
protect
immun
viral
pathogen
wherea
intent
antifertil
vaccin
caus
immun
respons
vaccin
individu
way
critic
reproduct
process
interrupt
elicit
immun
respons
antifertil
vaccin
need
contain
antigen
contracept
properti
achiev
either
manufactur
vaccin
use
appropri
compon
deriv
nativ
protein
transgen
protein
harvest
purifi
bacteri
fungal
sourc
wide
use
approach
genet
manipul
live
vaccin
vector
antifertil
compon
vaccin
suppli
exampl
genet
engin
viru
shellam
genet
engin
suitabl
viral
vector
proven
success
method
overcom
shortcom
convent
vaccin
develop
jackson
et
al
howev
vaccin
current
use
wildlif
wide
geograph
scale
one
develop
use
biotechnolog
genet
engin
vaccin
base
genet
alter
vaccinia
viru
contain
immunogen
compon
rabi
viru
brochier
et
al
unfortun
potenti
vaccinia
viru
indiscrimin
infect
wide
rang
speci
includ
human
imped
gener
use
vaccin
vector
exampl
applic
antifertil
vaccin
wildlif
reason
altern
speciesspecif
vector
canin
herpesviru
chv
canin
adenoviru
cadv
current
research
use
live
viral
vector
deliv
vaccin
antigen
alreadi
use
variou
antifertil
vaccin
prototyp
jackson
et
al
redwood
et
al
kerr
et
al
number
biolog
criteria
need
consid
influenc
choic
viru
vaccin
vector
shellam
boyl
among
exampl
speciesspecif
vector
abil
viru
dissemin
within
popul
potenti
preexist
popul
immun
vector
intend
rout
immun
critic
suitabl
vector
genom
accommod
addit
heterolog
dna
without
disrupt
essenti
viral
gene
function
case
wildlif
oral
vaccin
practic
aspect
viru
stabil
bait
need
also
consid
base
serolog
evid
european
red
fox
appear
suscept
mani
viral
infect
commonli
describ
domest
dog
truyen
et
al
garcelon
et
al
regard
potenti
virus
vaccin
vector
wild
canid
howev
appear
suitabl
candid
focus
attent
chv
potenti
vaccin
vector
wild
fox
sever
reason
previou
studi
shown
fox
experiment
infect
chv
caus
longlast
seroposit
fox
reubel
et
al
oral
infect
fox
shed
chv
environ
transmiss
contact
fox
observ
although
viral
dna
detect
site
latenc
spinal
ganglia
infect
fox
reactiv
viru
could
observ
even
high
dose
corticosteroid
treatment
reubel
et
al
conjunct
antibodi
preval
domest
dog
popul
report
reach
gaskel
willoughbi
indic
chanc
viru
transmit
fox
fox
canid
low
contrast
high
seropreval
dog
low
percentag
wild
fox
investig
australia
robinson
csiro
se
canberra
australia
person
commun
part
europ
truyen
et
al
antibodi
chv
lack
popul
immun
vaccin
vector
may
critic
advantag
potenti
canid
virus
cadv
common
fox
truyen
et
al
garcelon
et
al
riley
et
al
furthermor
previous
shown
chv
genom
capabl
accommod
heterolog
transgen
pathogen
rabi
viru
neospora
caninum
abl
confer
protect
immun
domest
dog
nishikawa
et
al
xuan
et
al
final
develop
bacteri
artifici
chromosom
system
chv
recent
report
strive
et
al
system
expect
greatli
facilit
genet
manipul
viral
genom
enabl
quick
modif
trait
insert
differ
antigen
remov
essenti
gene
gener
replic
defect
nondissemin
virus
aim
present
studi
explor
practic
aspect
use
chv
vaccin
vector
antifertil
vaccin
wild
fox
laboratori
part
experi
concern
suitabl
chv
freezedri
use
variou
experiment
commerci
bait
storag
differ
condit
chvbait
test
two
fox
trial
potenti
induc
chvspecif
immun
follow
oral
bait
canin
herpesviru
strain
kindli
provid
prof
michael
studdert
depart
veterinari
scienc
univers
melbourn
parkvil
vic
australia
use
fox
experi
molecular
characterist
previous
describ
reubel
et
al
reubel
et
al
chv
grown
madin
darbi
canin
kidney
cell
mdck
american
type
cultur
collect
number
cell
cultur
passag
use
laboratori
experi
bait
trial
two
preliminari
experi
stabil
freezedri
chv
fdchv
compar
liquid
chv
lchv
differ
storag
condit
potenti
stabil
effect
sucros
merck
australia
bovin
serum
albumin
bsa
astral
scientif
australia
fetal
calf
serum
fc
invitrogen
australia
freezedri
process
also
test
experi
aliquot
chv
tissu
cell
cultur
infecti
dose
per
ml
tcid
ml
store
either
liquid
freezedri
form
variou
period
time
month
differ
storag
temperatur
chv
freezedri
h
flexidri
mp
bench
top
lyophil
ft
system
stoneridg
ny
usa
accord
manufactur
instruct
remain
infect
viru
determin
differ
time
point
titrat
mdck
cell
experi
b
sucros
bsa
fc
ad
liquid
freezedri
chv
tcid
ml
freezedri
final
concentr
wv
chang
viru
infect
measur
follow
differ
storag
condit
infect
sampl
store
determin
month
storag
sampl
store
h
cell
cultur
check
daili
cytopath
effect
viru
titr
calcul
use
spearmankaerb
method
kaerber
express
tcid
ml
two
commerci
avail
fox
bait
use
fox
bait
trial
probait
kindli
provid
nicki
marlow
depart
conserv
land
manag
wa
australia
sausageform
bait
made
dri
kangaroo
meat
foxoff
bait
kindli
provid
linton
stapl
appli
biotechnolog
melbourn
vic
australia
manufactur
cubicl
press
dri
dog
food
materi
two
bait
use
evalu
viabil
chv
incorpor
bait
materi
preliminari
bait
trial
mous
carcass
also
use
vaccin
bait
mice
mu
domesticu
bred
anim
hous
csiro
sustain
ecosystem
canberra
australia
determin
stabil
fdchv
incorpor
bait
ml
aliquot
chv
tcid
ml
frozen
freezedri
h
flexidri
mp
bench
top
lyophil
ft
system
accord
manufactur
instruct
bait
matrix
probait
foxoff
bait
cut
mm
thick
slice
autoclav
place
steril
petri
dish
evenli
cover
mg
fdchv
petri
dish
three
replic
sampl
store
month
differ
storag
temperatur
remain
viru
infect
evalu
titrat
mdck
cell
chvcover
bait
matrix
homogenis
mix
ml
steril
cell
cultur
media
incub
h
sampl
centrifug
rpm
ms
supernat
use
titrat
one
hundr
microlitr
supernat
ad
five
replic
mdck
cell
cell
cultur
plate
incub
day
cell
cultur
check
daili
cytopath
effect
viru
titr
calcul
use
spearmankaerb
method
kaerber
express
tcid
ml
preliminari
experi
possibl
cytotox
probait
foxoff
bait
matrix
mdck
cell
examin
bait
cut
sugar
cube
size
piec
approxim
cm
autoclav
immers
cell
cultur
media
sampl
incub
h
homogenis
centrifug
supernat
use
inocul
cell
cultur
monitor
cytotox
effect
day
twentyfour
adult
wild
european
red
fox
male
femal
age
year
select
studi
fox
purchas
cub
farmer
new
south
wale
victoria
rear
anim
facil
csiro
sustain
ecosystem
canberra
australia
fox
vaccin
canin
distemp
viru
canin
parvoviru
canin
parainfluenza
viru
commerci
avail
vaccin
protech
tm
webster
australia
prior
bait
trial
fox
fed
daili
can
dri
dog
food
unrestrict
access
drink
water
fox
hous
individu
outdoor
cage
equip
wooden
shelter
box
project
approv
csiro
sustain
ecosystem
anim
ethic
committe
preliminari
trial
foxoff
bait
mous
carcass
prepar
tcid
either
lchv
fdchv
fed
eight
femal
fox
two
fox
per
group
foxoff
bait
prepar
make
six
indent
surfac
bait
fill
lchv
bait
frozen
use
trial
appli
fdchv
foxoff
bait
roll
milk
powder
contain
tcid
viru
store
mous
carcass
bait
prepar
make
six
subcutan
incis
rump
mous
fill
milk
powder
contain
fdchv
liquid
chv
appli
carcass
subcutan
inject
viru
six
site
two
control
fox
given
dose
fdchv
either
intranas
peror
fox
kept
individu
cage
allow
verif
bait
consumpt
increas
likelihood
fox
eat
bait
fox
starv
h
prior
begin
bait
experi
fox
receiv
one
bait
per
day
consecut
day
procedur
repeat
day
first
day
fox
monitor
daili
sign
clinic
diseas
bodi
temperatur
bodi
weight
record
regular
base
blood
collect
everi
week
serum
antibodi
respons
chv
determin
focuselisa
felisa
describ
reubel
et
al
mouth
nose
eye
secret
one
combin
swab
vagin
secret
collect
period
day
determin
presenc
infecti
chv
viral
dna
viru
isol
pcr
steril
cotton
swab
sarstedt
germani
use
collect
secret
eye
nose
throat
swab
one
vagin
prepuc
secret
swab
two
prior
sampl
swab
kept
steril
tube
contain
ml
steril
phosphat
buffer
salin
pb
sampl
fluid
squeez
cotton
store
second
bait
trial
foxoff
probait
bait
prepar
tcid
fdchv
fed
individu
kept
fox
male
femal
bait
roll
milk
powder
contain
tcid
viru
store
prior
start
actual
vaccin
trial
fox
fed
empti
bait
contain
viru
day
adjust
eat
bait
actual
trial
fox
receiv
one
bait
per
day
consecut
day
procedur
repeat
week
clinic
virolog
serolog
evalu
perform
describ
first
trial
antibodi
chv
determin
plasma
sampl
felisa
describ
reubel
et
al
mdck
cell
grown
microtit
plate
inocul
duplic
ml
swab
sampl
inocul
cell
cultur
incub
co
day
check
daili
cytopath
effect
supernat
well
visibl
cytopath
effect
harvest
assay
pcr
presenc
chv
dna
two
differ
pcr
assay
use
trial
sampl
first
bait
trial
analys
convent
nest
pcr
detect
chv
thymidin
kinas
tk
gene
describ
reubel
et
al
second
bait
trial
realtim
pcr
develop
appli
realtim
pcr
perform
use
corbett
rotor
gene
corbett
research
sydney
australia
data
analysi
perform
softwar
provid
manufactur
primer
realtim
pcr
design
use
webbas
version
lux
tm
design
softwar
invitrogen
melbourn
australia
primer
fluorogen
revers
primer
amplifi
nucleotid
region
within
thymidin
kinas
region
chv
genom
pcr
reaction
set
accord
supplier
instruct
cycl
condit
includ
denatur
min
repeat
denatur
anneal
extens
follow
final
extens
min
plasmid
contain
one
copi
tk
gene
strive
et
al
use
quantit
standard
realtim
pcr
abl
detect
littl
copi
target
dna
cell
cultur
infect
lchv
fdchv
decreas
rapidli
higher
storag
temperatur
tabl
store
lchv
lost
infect
week
wherea
remain
infecti
month
store
freezedri
form
freezedri
appear
preserv
chv
infect
also
storag
temperatur
viru
infect
lchv
decreas
week
storag
anoth
week
contrast
infect
fdchv
decreas
week
remain
stabl
end
experi
substanti
differ
viru
infect
lchv
fdchv
store
prepar
retain
infect
month
reduct
viru
titr
freezedri
gener
reduc
infect
chv
approxim
independ
stabil
ad
viru
solut
addit
sucros
chv
freezedri
increas
stabil
viru
five
storag
temperatur
sucros
also
benefici
viru
infect
viru
store
liquid
tabl
h
exposur
visibl
cytotox
effect
either
bait
matrix
alon
viru
cell
cultur
observ
clear
differ
howev
two
bait
regard
viru
inactiv
properti
time
fig
adsorpt
chv
foxoff
matrix
result
complet
loss
infect
earli
month
exposur
reduct
viru
infect
wherea
process
probait
caus
reduct
substanti
chang
month
similarli
chv
expos
foxoff
month
viru
infect
reduc
wherea
littl
chang
infect
notic
exposur
probait
storag
temperatur
month
result
reduct
infect
foxoff
reduct
probait
three
month
exposur
foxoff
complet
destroy
infect
chv
wherea
chv
probait
bait
retain
infect
tcid
ml
reduct
storag
benefici
viru
stabil
bait
month
contact
foxoff
infect
chv
decreas
addit
expos
total
month
contrast
fox
bait
trial
bait
accept
first
bait
fox
appear
individu
prefer
regard
palat
bait
bait
eaten
within
first
h
distribut
whilst
other
touch
second
day
bait
howev
fox
eventu
ate
six
bait
offer
tabl
second
bait
everi
fox
ate
bait
within
h
distribut
cage
none
fox
fed
chvspike
bait
none
control
fox
manual
vaccin
either
peror
intranas
show
clinic
sign
ill
bodi
temperatur
bodyweight
fox
chang
substanti
follow
exposur
chv
data
shown
none
fox
includ
control
shed
infecti
viru
mouthnoseey
vagin
secret
determin
viru
isol
cell
cultur
contrast
chv
dna
readili
detect
pcr
chv
tk
gene
secret
bait
fox
sever
day
trial
period
tabl
mouth
noseey
secret
peror
intranas
inocul
control
fox
pcrposit
earli
day
post
inocul
viral
dna
detect
extend
period
time
four
fox
consecut
day
first
inocul
also
consist
second
inocul
pcr
posit
frequent
also
evenli
distribut
baitf
fox
compar
manual
inocul
fox
although
individu
chv
dna
mouthnoseey
secret
consecut
day
first
bait
second
bait
chv
dna
occasion
detect
anim
four
manual
vaccin
fox
pcr
posit
averag
day
day
test
compar
averag
day
test
bait
fox
howev
individu
pcr
posit
eight
fox
vari
consider
except
fox
chv
dna
also
detect
vagin
secret
taken
bait
manual
vaccin
fox
although
much
lower
frequenc
logist
reason
sampl
taken
first
day
trial
peror
intranas
inocul
control
fox
seroconvert
week
chv
administr
fig
feed
chvspike
mous
carcass
foxoff
bait
prepar
liquid
freezedri
viru
also
induc
specif
antichv
serum
antibodi
respons
fox
although
strong
caus
manual
peror
intranas
vaccin
control
fox
fig
c
gener
appear
fox
prefer
probait
sausag
bait
foxoff
bait
tabl
first
observ
adapt
prebait
period
empti
bait
fox
probait
group
ate
bait
first
day
second
third
compar
bait
first
day
second
third
day
fox
foxoff
group
howev
fourth
day
prebait
fox
group
eaten
bait
similar
prefer
probait
bait
seen
chvcoat
bait
fed
end
first
vaccin
period
fox
probait
group
eaten
bait
compar
foxoff
group
end
second
bait
period
number
probait
group
foxoff
group
fig
antichv
serum
antibodi
respons
fox
manual
inocul
either
peror
intranas
freezedri
fd
liquid
l
chvor
b
fed
mous
carcass
bait
coat
lchv
fdchv
c
fed
foxoff
bait
coat
lchv
fdchv
evid
averag
bodi
temperatur
bodi
weight
fox
either
experiment
group
clinic
affect
eat
chvbait
fig
howev
bodi
weight
bodi
temperatur
individu
fox
fluctuat
consider
trial
period
infecti
chv
isol
mouthnos
eye
secret
one
combin
swab
genit
secret
second
swab
fox
either
group
howev
chv
dna
detect
secret
fox
trial
evalu
realtim
pcr
tabl
mucos
secret
taken
mouthnoseey
swab
posit
sever
occas
chv
bait
vaccin
small
number
sampl
one
experiment
group
posit
chv
dna
earli
day
first
bait
period
peak
posit
pcr
swab
occur
day
post
vaccin
substanti
differ
observ
two
experiment
group
none
fox
foxoff
group
posit
pcr
sampl
second
bait
period
wherea
two
fox
probait
group
posit
day
respect
contrast
mouthnoseey
secret
posit
chv
dna
fox
sever
day
genit
swab
posit
fox
probait
group
foxoff
group
infrequ
five
six
posit
swab
origin
male
fox
fox
group
except
fox
seroconvert
earli
week
first
bait
vaccin
fig
antibodi
titr
increas
time
level
around
week
post
vaccin
reach
averag
titr
least
boost
effect
second
vaccin
observ
antichv
antibodi
titr
gener
higher
fox
fed
probait
bait
compar
fed
foxoff
bait
howev
even
fox
eaten
offer
foxoff
bait
last
one
seroconvert
week
post
vaccin
maintain
antibodi
titr
week
post
vaccin
aim
present
studi
investig
practic
aspect
use
chv
vaccin
vector
oral
bait
wild
fox
varieti
biolog
criteria
need
consid
influenc
choic
viru
vaccin
vector
shellam
boyl
among
exampl
speciesspecif
vector
potenti
preexist
popul
immun
vector
intend
rout
immun
wildlif
vaccin
usual
deliv
peror
bait
stabil
viru
differ
environment
condit
suitabl
viru
freezedri
incorpor
bait
particular
import
predict
vivo
efficaci
live
antivir
vaccin
made
determin
infect
vaccin
viru
cell
cultur
vitro
review
see
terpstra
kroes
therefor
explor
laboratori
experi
suitabl
condit
freezedri
chv
variou
storag
condit
vaccin
addit
would
affect
infect
viru
chv
yet
use
freezedri
form
vaccin
compon
oral
bait
also
test
fox
trial
whether
peror
applic
chvcoat
bait
could
induc
antivir
antibodi
respons
bait
fox
freezedri
storag
temperatur
stabil
effect
viabil
chv
cell
cultur
viru
chv
incorpor
bait
differ
viru
infect
fdchv
lchv
week
storag
sampl
kept
howev
freezedri
consider
preserv
viru
infect
storag
temperatur
viru
titr
fdchv
decreas
compar
decreas
liquid
viru
similarli
fdchv
surviv
week
wherea
infect
lchv
lost
week
addit
sucros
also
benefici
stabil
viru
freezedri
liquid
similar
result
publish
herpesvirus
varicella
zoster
rinderpest
viru
freezedri
addit
sugar
substanti
increas
viabil
virus
grose
et
al
harper
et
al
worral
et
al
clear
differ
observ
regard
influenc
bait
materi
viru
infect
storag
matrix
bait
toxic
cell
cultur
howev
exposur
fdchv
foxoff
bait
time
detriment
viru
infect
exposur
probait
bait
matrix
reason
differ
establish
foxoff
bait
appear
higher
moistur
content
probait
bait
may
contribut
factor
quicker
viru
inactiv
bait
temperatur
moistur
known
import
factor
affect
viru
surviv
environ
hurst
et
al
therefor
surpris
temperatur
destroy
infect
fdchv
bait
within
week
howev
fdchv
surviv
consider
longer
probait
bait
temperatur
foxoff
bait
viru
infect
complet
lost
within
month
store
within
month
store
contrast
still
consider
amount
infecti
viru
left
probait
bait
store
importantli
fdchv
loos
infect
store
probait
bait
month
find
demonstr
chv
freezedri
incorpor
bait
store
extend
fig
bodi
weight
fox
follow
uptak
uptak
probait
b
foxoff
bait
coat
freezedri
chv
individu
fox
depict
symbol
averag
shown
black
line
period
time
without
loos
much
infect
presum
potenc
vaccin
test
chvbait
fox
result
sever
essenti
observ
although
due
low
number
fox
per
experiment
group
trial
need
consid
preliminari
henc
statist
signific
deduc
use
mous
carcass
foxoff
bait
spike
liquid
freezedri
chv
determin
whether
fox
would
seroconvert
upon
consum
bait
show
first
time
peror
intranas
appli
fdchv
induc
antivir
anti
tabl
detect
chv
dna
realtim
pcr
mouthnoseey
secret
genit
secret
b
fox
bait
foxoff
probait
bait
coat
freezedri
chv
b
bait
day
posit
neg
nd
done
bodi
respons
fox
chv
pathogen
infecti
chv
shed
environ
although
manual
administr
chv
control
fox
induc
higher
antibodi
titr
bait
feed
result
clearli
warrant
investig
chv
administr
bait
second
fox
trial
focus
use
two
commerci
avail
bait
foxoff
probait
coat
fdchv
fox
appear
prefer
probait
bait
compar
foxoff
bait
reflect
tempor
uptak
bait
overal
number
bait
taken
observ
fox
tend
cach
foxoff
bait
possibl
later
consumpt
wherea
probait
bait
usual
eaten
soon
suppli
probaitbait
fox
higher
averag
antichv
antibodi
fox
foxoff
group
could
explain
higher
intak
infecti
chv
probait
group
like
bait
eaten
soon
distribut
exposur
viru
environ
expect
inactiv
viru
time
thu
potenc
induc
immun
respons
reduc
first
trial
none
bait
fox
becam
ill
shed
infecti
viru
environ
although
chv
dna
found
secret
fox
first
bait
mouthnoseey
secret
pcr
posit
day
genit
secret
occasion
posit
second
bait
viral
dna
detect
secret
two
fox
eleven
fox
seroconvert
time
week
post
vaccin
like
newli
develop
antivir
immun
prevent
viral
replic
viral
dna
shed
five
six
posit
genit
swab
collect
male
fox
previou
studi
shown
system
viru
replic
viremia
follow
oral
chv
intak
unlik
reubel
et
al
seem
rather
probabl
pcr
posit
genit
swab
caus
presenc
chvcontain
saliva
trough
groom
lick
noteworthi
fox
ate
none
bait
first
bait
period
seroconvert
week
could
carri
bait
mouth
cach
possibl
lick
enough
fdchv
resorb
oral
mucosa
caus
antivir
antibodi
respons
feed
fdchvcoat
bait
induc
antichv
antibodi
fox
corrobor
serolog
find
preliminari
trial
first
report
chv
success
use
freezedri
form
oral
bait
fox
bait
fox
seroconvert
none
becam
ill
consid
specif
chv
canid
innocu
fox
follow
oral
bait
lack
popul
immun
speci
chvappear
mani
properti
critic
requir
recombin
vaccin
vector
wild
fox
